Statin-intolerant patients need a different type of clinical trial
(Medical Xpress) -- Millions of people take statins, the blockbuster drug that lowers low-density lipoprotein (LDL), the so-called bad cholesterol. But as many as 20 percent of them develop adverse effects such as muscle fatigue and weakness and impaired cognition. Rockefeller University scientists Patricia Maningat and Jan L. Breslow, writing in this weeks issue of the New England Journal of Medicine, argue that clinical trials need to be designed to address the needs of statin-intolerant patients.
Statins are so widely used that side effects can translate into substantial public health problems, says Breslow, Frederick Henry Leonhardt Professor and head of the Laboratory of Biochemical Genetics and Metabolism. Its imperative that we design special clinical trials, such as pragmatic trials, to determine the best treatment options for patients who have adverse effects from statins.
Statins, first introduced in 1987, work by blocking an enzyme called HMG-CoA reductase, which plays a key role in the livers production of cholesterol. Randomized clinical trials have shown that side effects occur in less than 5 percent of patients who take statins, although as many as 20 percent are reported to experience side effects in clinical practice. Maningat and Breslow attribute this discrepancy to how patients are selected for clinical trials, which typically under enroll two groups likely to experience statin-related side effects older patients and women as well as patients who drink large amounts of alcohol, take several other medications, or have complicated medical conditions. The problem, the researchers say, is that these groups are likely to be prescribed statins in the real world.
According to the researchers, the most common side effect of statin use, a muscular condition known as statin-associated myopathy, lacks a standard definition, which also leads to the discrepancy of reported adverse effects. For example, high levels of an enzyme called creatine phosphokinase typically indicate statin-associated myopathy, but this condition is not necessarily accompanied by elevated levels of this enzyme. Finally, cognitive impairment, the most common neurologic problem associated with statin use, is generally not measured in the clinic or its disregarded as a consequence of aging.
Maningat and Breslow argue that introduction of new drugs for people who cant tolerate statins lags because most non-statin therapies are tested in clinical trials as additive therapies on top of statins. For example, in a recent trial on the benefits of combining niacin with statins, called the AIM-HIGH trial, 94 percent of those enrolled were taking a statin drug at the time they were enrolled. In this study, niacin combined with a statin was found to have no cardiovascular benefits and a trend towards increased risk of ischemic strokes.
In the AIM-HIGH trial, niacin was not found to be useful when combined with a statin, and indeed, it might be harmful, says Breslow. Fortunately, we do know that niacin alone can be beneficial. However, if a new drug was tested with a statin and the same result was found, it would be impossible to determine if it had standalone benefits and its value would be lost for statin-intolerant patients.
Since statins have been shown to reduce the risk of cardiovascular disease and have become standard of care, placebos are considered by some experts to be unacceptable when studying the effectiveness of new cholesterol modifying drugs, and therefore most studies employ the study drug as an add-on to statin therapy. That severely complicates the conduct of meaningful trials for statin-intolerant patients. But Maningat and Breslow say that pragmatic trials, which occur in the context of usual care and recruit patients from broad a variety of practice settings, may be well suited for determining the best treatment options for patients who experience side effects from statins. In pragmatic trials, patients and doctors usually arent blinded to the treatment and have the option to adjust or discontinue the treatment.
Although less rigidly controlled than randomized trials, pragmatic trials are conducted in real-world settings and provide valuable information and guidance for clinical practice, Breslow says. Given the complexity of statin intolerance, physicians need a simple way to identify patients who experience side effects. Maningat and Breslow suggest that patients who find their quality of life diminished to the point where they discontinue or change their statin regimen be defined as statin intolerant.
Enrolling patients in pragmatic trials, the researchers say, would involve, among other things, simplifying the definition of statin intolerance and screening patients to determine their perception of their symptoms, quantify the effects of statin intolerance on their daily activities and monitor changes in quality of life.
Were not suggesting that pragmatic clinical trials for statin-intolerant patients would be easy or inexpensive, but this populations needs are not being met, says Maningat, who is a research associate in Breslows lab. Its time to begin a dialogue on the best way to meet them.
More information: The New England Journal of Medicine online: November 15, 2011, Needed: Pragmatic Clinical Trials for Statin-Intolerant Patients, Patricia Maningat and Jan L. Breslow
Journal reference: New England Journal of Medicine
Provided by Rockefeller University
- Study finds no link between statins and cancer risk Jul 25, 2011 | not rated yet | 0
- A new use for statins? Oct 18, 2011 | not rated yet | 0
- Tendon complications, though rare, linked to statins Feb 28, 2008 | not rated yet | 0
- Pneumonia death rate lower among people who take statins Apr 05, 2011 | not rated yet | 0
- 'Statins' linked to improved survival in kidney transplant recipients Jul 24, 2008 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Why is zone 1 in liver more prone to ischemic injury?
4 hours ago Hi, Is it because around central vein, there is only deoxygenated blood from the vein where as in the periphery there is hepatic artery. Also why...
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013 As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
- More from Physics Forums - Medical Sciences
More news stories
(Medical Xpress)—According to the World Health Organization, approximately 70 million couples experience infertility worldwide. Current data suggests that nearly one third of infertility disorders are due ...
Medical research 3 minutes ago | not rated yet | 0
Every day, their baby stopped breathing, his collapsed bronchus blocking the crucial flow of air to his lungs. April and Bryan Gionfriddo watched helplessly, just praying that somehow the dire predictions ...
Medical research 15 hours ago | 5 / 5 (2) | 0
The human gut is loaded with commensal bacteria – "good" microbes that, among other functions, help the body digest food. The gastrointestinal tract contains literally trillions of such cells, and yet the ...
Medical research 19 hours ago | 5 / 5 (3) | 0 |
Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.
Medical research 19 hours ago | 4.9 / 5 (10) | 1 |
On May 22, JoVE will publish details of a technique to measure the health of human genetic material in relation to a patient's age. The method is demonstrated by the laboratory of Dr. Gil Atzmon at New York's Albert Einste ...
Medical research 22 hours ago | not rated yet | 0
(Medical Xpress)—Researchers at the University of Virginia School of Medicine have identified a promising target for treating glioblastoma, one that appears to avoid many of the obstacles that typically frustrate efforts ...
48 minutes ago | not rated yet | 0 |
(Medical Xpress)—The first symptoms of major depression may be behavioral, but the common mental illness is based in biology—and not limited to the brain.
43 minutes ago | 5 / 5 (1) | 0 |
(Medical Xpress)—Scientists at Emory Vaccine Center have shown that an immune regulatory molecule called IL-21 is needed for long-lasting antibody responses in mice against viral infections.
37 minutes ago | not rated yet | 0 |
Human breastmilk responds quickly to protect the child when there is an infection in mothers or babies, according to new international research led by The University of Western Australia.
49 minutes ago | not rated yet | 0
More than half of patients diagnosed with Non-Hodgkin Lymphoma (NHL) are now surviving the disease thanks to improved diagnosis and treatment, according to a new report1 from Cancer Research UK.
23 minutes ago | not rated yet | 0
(Medical Xpress)—There is no significant risk directly associated with air travel during pregnancy, even at advanced gestation, says report by the University of Liverpool.
13 minutes ago | not rated yet | 0